High-performance liquid chromatographic determination of mexiletine enantiomers in plasma using direct and indirect enantioselective separations

被引:27
作者
Lanchote, VL
Bonato, PS
Dreossi, SAC
Goncalves, PVB
Cesarino, EJ
Bertucci, C
机构
[1] UNIV SAO PAULO,DEPT SOCIAL MED,FAC MED RIBEIRAO PRETO,BR-05508 SAO PAULO,BRAZIL
[2] UNIV PISA,DIPARTIMENTO CHIM & CHIM IND,CNR,CTR STUDIO MACROMOL STEREORDINATE & OTTICAMENTE A,PISA,ITALY
来源
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS | 1996年 / 685卷 / 02期
关键词
enantiomer separation; mexiletine;
D O I
10.1016/S0378-4347(96)00195-8
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Two methods were developed for the determination of mexiletine enantiomers in plasma samples suitable for studies on the stereoselective disposition of this drug. Both methods used fluorescence detection to improve sensitivity and selectivity. The direct enantioselective separation was based on the chiral resolution of mexiletine-2-naphthamide derivatives on a Chiralcel OJ column. The calibration curves were linear over the concentration range 50-500 ng/ml for each enantiomer; therefore the method can be used only for therapeutic monitoring, drug interaction and multiple dose pharmacokinetic studies. The indirect method was based on the formation of diastereomers using o-phthaldialdehyde and N-acetyl-L-cysteine reagents. The diastereomers were resolved on a reversed-phase RP-18 column. The method proved to be suitable for single or multiple dose pharmacokinetic studies based on the low quantification limit (1 ng/ml) and the broader linear range (1-1000 ng/ml) obtained.
引用
收藏
页码:281 / 289
页数:9
相关论文
共 16 条
  • [1] ALBOFATHI Z, 1992, J CHROMATOGR, V579, P366
  • [2] KINETICS OF ORAL AND INTRAVENOUS MEXILETINE - LACK OF EFFECT OF CIMETIDINE AND RANITIDINE
    BROCKMEYER, NH
    BREITHAUPT, H
    FERDINAND, W
    VONHATTINGBERG, M
    OHNHAUS, EE
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 36 (04) : 375 - 378
  • [3] THE METABOLISM OF MEXILETINE IN RELATION TO THE DEBRISOQUINE SPARTEINE-TYPE POLYMORPHISM OF DRUG OXIDATION
    BROLY, F
    VANDAMME, N
    LIBERSA, C
    LHERMITTE, M
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 32 (04) : 459 - 466
  • [4] DIRECT ANALYSIS OF THE ENANTIOMERS OF MEXILETINE AND ITS METABOLITES IN PLASMA AND URINE USING AN HPLC-CSP
    FIEGER, H
    WAINER, IW
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1993, 11 (11-12) : 1173 - 1179
  • [5] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR RESOLVING THE ENANTIOMERS OF MEXILETINE AND 2 MAJOR METABOLITES ISOLATED FROM MICROBIAL FERMENTATION MEDIA
    FREITAG, DG
    FOSTER, RT
    COUTTS, RT
    PASUTTO, FM
    [J]. JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1993, 616 (02): : 253 - 259
  • [6] STEREOSELECTIVE DISPOSITION OF MEXILETINE IN MAN
    GRECHBELANGER, O
    TURGEON, J
    GILBERT, M
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 (05) : 481 - 487
  • [7] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR MEXILETINE ENANTIOMERS IN HUMAN-PLASMA
    GRECHBELANGER, O
    TURGEON, J
    GILBERT, M
    [J]. JOURNAL OF CHROMATOGRAPHY, 1985, 337 (01): : 172 - 177
  • [8] KWORK DKW, 1994, J CHROMATOGR, V661, P271
  • [9] INFLUENCE OF DEBRISOQUINE HYDROXYLATION PHENOTYPE ON THE PHARMACOKINETICS OF MEXILETINE
    LLEDO, P
    ABRAMS, SML
    JOHNSTON, A
    PATEL, M
    PEARSON, RM
    TURNER, P
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (01) : 63 - 67
  • [10] MEXILETINE - PHARMACOLOGY AND THERAPEUTIC USE
    MANOLIS, AS
    DEERING, TF
    CAMERON, J
    ESTES, NAM
    [J]. CLINICAL CARDIOLOGY, 1990, 13 (05) : 349 - 359